Sitagliptin + Metformin Compared to Metformin Monotherapy and Placebo in Women With a Recent GDM

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2016 by Woman's
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Karen Elkind-Hirsch, Woman's
ClinicalTrials.gov Identifier:
NCT01856907
First received: May 14, 2013
Last updated: February 23, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)